组织陈列-产品详情

home > TISSUE ARRAYS > Uterus > FDU961

Type
- FFPE
- FROZEN TISSUE
Identity
Organ
- Liver
- Esophagus
- Ovary
- Stomach
- Lung
- Colon
- Rectum
- Kidney
- Breast
- Endometrium
- Uterus
- Bladder
- Pancreas
- Skin
- Penis
- Testis
- Soft_Tissue
- Bone/Cartilage
- Oral/Cavity
- Bone/Marrow
- Heart
- Spleen
- Head/Neck
- Vulva
- Melanoma
- Appendix
- Intestine
- Adrenal Gland
- Thymus
- Fallopian tube
- Mouse
- Fetus
- Rat
- Monkey (Rhesus) (Normal)-RsFPT
- Monkey (Cynomolgus) (Normal)-CyFPT
- Dog
- Multiple organ
- Gall bladder and bile duct
- Esophagogastric junction
Types/Disease
Cores
Cases

Cores:

96

CASES:

48

Core Diameter(mm):

1

Thickness(µm):

5

Row number:

10

Column number:

10

Tissue Array Type:

FFPE

Species:

Human

FDU961

$325.00

Description: Cervix cancer array with matched cancer adjacent tissue, including pathology grade, TNM and clinical stage, 48 cases/96 cores

Details: Cervical carcinoma microarray with matched cancer adjacent tissue, containing 36 cases of squamous cell carcinoma, 9 adenocarcinoma, 2 adenosquamous carcinoma, 1 carcinoma in situ, with matched cancer adjacent cervix tissue, duplicate cores per case

Applications: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

Please Select Tissue Array Type:

Unstained

H&E

Tag:

96 Cores 48 Cases Uterus special price Adjacent duplicate cores per case

Add To Cart

Outright purchase

Note

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

Specification sheet
Overlapping case
Download specifications

Legend:

Car-Cardia Eso-Fsophagus

Malignant(*)
AT(*)
Malignant(IB1)
AT(IB1)
Malignant(IIA2)
_ma

TISSUE ARRAYS
FDU961

	1	2	3	4	5	6	7	8	9	10
A	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
B	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
C	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
D	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
E	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
F	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
G	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
H	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
I	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
J	Cer	Cer	Cer	Cer	Cer	Cer					_ma

FDU961

Age:
Sex:
Organ/Anatomic Site:
Pathology diagnosis:
Grade:
TNM:
Stage:
Tissue ID.:
Type:

Pos	No.	Age	Sex	Organ/Anatomic Site	Pathology diagnosis	Grade	TNM	Stage	Type
A1	1	47	F	Cervix	Squamous cell carcinoma	1	*	*	Malignant
A2	2	47	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
A3	3	43	F	Cervix	Squamous cell carcinoma	1	*	*	Malignant
A4	4	43	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
A5	5	51	F	Cervix	Squamous cell carcinoma	2	*	*	Malignant
A6	6	51	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
A7	7	61	F	Cervix	Squamous cell carcinoma	2	*	*	Malignant
A8	8	61	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
A9	9	45	F	Cervix	Squamous cell carcinoma	2	T1b1N0M0	IB1	Malignant
A10	10	45	F	Cervix	Cancer adjacent cervix tissue	*	T1b1N0M0	IB1	AT
B1	11	31	F	Cervix	Squamous cell carcinoma	2	*	*	Malignant
B2	12	31	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
B3	13	48	F	Cervix	Squamous cell carcinoma	2	T1b1N0M0	IB1	Malignant
B4	14	48	F	Cervix	Cancer adjacent cervix tissue (CIN II-III)	*	*	*	AT
B5	15	42	F	Cervix	Squamous cell carcinoma	2	T1b1N0M0	IB1	Malignant
B6	16	42	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
B7	17	68	F	Cervix	Squamous cell carcinoma	2	*	*	Malignant
B8	18	68	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
B9	19	48	F	Cervix	Squamous cell carcinoma	2	T1b1N0M0	IB1	Malignant
B10	20	48	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
C1	21	37	F	Cervix	Squamous cell carcinoma	2	T1b1N0M0	IB1	Malignant
C2	22	37	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
C3	23	41	F	Cervix	Squamous cell carcinoma	2	T1b1N0M0	IB1	Malignant
C4	24	41	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
C5	25	40	F	Cervix	Squamous cell carcinoma	2	T1b1N0M0	IB1	Malignant
C6	26	40	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
C7	27	71	F	Cervix	Squamous cell carcinoma	2	T1b1N0M0	IB1	Malignant
C8	28	71	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
C9	29	42	F	Cervix	Squamous cell carcinoma	2	T1b1N0M0	IB1	Malignant
C10	30	42	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
D1	31	44	F	Cervix	Squamous cell carcinoma	2	*	*	Malignant
D2	32	44	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
D3	33	48	F	Cervix	Squamous cell carcinoma	2	*	*	Malignant
D4	34	48	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
D5	35	49	F	Cervix	Squamous cell carcinoma	2	*	*	Malignant
D6	36	49	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
D7	37	63	F	Cervix	Squamous cell carcinoma	2	*	*	Malignant
D8	38	63	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
D9	39	59	F	Cervix	Squamous cell carcinoma	2	*	*	Malignant
D10	40	59	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
E1	41	47	F	Cervix	Squamous cell carcinoma	2	*	*	Malignant
E2	42	47	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
E3	43	48	F	Cervix	Squamous cell carcinoma	2	T1b1N0M0	IB1	Malignant
E4	44	48	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
E5	45	48	F	Cervix	Squamous cell carcinoma (sparse)	2	*	*	Malignant
E6	46	48	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
E7	47	62	F	Cervix	Squamous cell carcinoma	2	*	*	Malignant
E8	48	62	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
E9	49	59	F	Cervix	Squamous cell carcinoma (sparse)	2	*	*	Malignant
E10	50	59	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
F1	51	51	F	Cervix	Squamous cell carcinoma	2	*	*	Malignant
F2	52	51	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
F3	53	31	F	Cervix	Squamous cell carcinoma	2	*	*	Malignant
F4	54	31	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
F5	55	67	F	Cervix	Squamous cell carcinoma	2	*	*	Malignant
F6	56	67	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
F7	57	56	F	Cervix	Squamous cell carcinoma	2--3	T1b1N0M0	IB1	Malignant
F8	58	56	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
F9	59	34	F	Cervix	Squamous cell carcinoma	2--3	*	*	Malignant
F10	60	34	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
G1	61	44	F	Cervix	Squamous cell carcinoma	3	T1b1N0M0	IB1	Malignant
G2	62	44	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
G3	63	39	F	Cervix	Squamous cell carcinoma	3	T1b1N0M0	IB1	Malignant
G4	64	39	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
G5	65	69	F	Cervix	Squamous cell carcinoma	3	*	*	Malignant
G6	66	69	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
G7	67	69	F	Cervix	Squamous cell carcinoma (sparse)	3	*	*	Malignant
G8	68	69	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
G9	69	57	F	Cervix	Squamous cell carcinoma	3	*	*	Malignant
G10	70	57	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
H1	71	57	F	Cervix	Squamous cell carcinoma	3	*	*	Malignant
H2	72	57	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
H3	73	32	F	Cervix	Adenocarcinoma	1--2	T1b1N0M0	IB1	Malignant
H4	74	32	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
H5	75	41	F	Cervix	Adenocarcinoma (sparse)	2	T1b1N0M0	IB1	Malignant
H6	76	41	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
H7	77	55	F	Cervix	Adenocarcinoma	2	T1b1N0M0	IB1	Malignant
H8	78	55	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
H9	79	50	F	Cervix	Adenocarcinoma	1	*	*	Malignant
H10	80	50	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
I1	81	42	F	Cervix	Adenocarcinoma	3	*	*	Malignant
I2	82	42	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
I3	83	44	F	Cervix	Adenocarcinoma	2	*	*	Malignant
I4	84	44	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
I5	85	44	F	Cervix	Adenocarcinoma	2	T1b1N0M0	IB1	Malignant
I6	86	44	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
I7	87	50	F	Cervix	Adenocarcinoma	2	T2a2N0M0	IIA2	Malignant
I8	88	50	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
I9	89	51	F	Cervix	Adenocarcinoma	2	*	*	Malignant
I10	90	51	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
J1	91	48	F	Cervix	Adenosquamous carcinoma	2--3	*	*	Malignant
J2	92	48	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
J3	93	46	F	Cervix	Adenosquamous carcinoma	2--3	*	*	Malignant
J4	94	46	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
J5	95	38	F	Cervix	Carcinoma in situ	*	*	*	Malignant
J6	96	38	F	Cervix	Cancer adjacent cervix tissue	*	*	*	AT
_marker_

Find overlapping cases with this tissue array:

FDU961

File Format: .xlsx

Release Date: 2025-01-17 15:58:54
Download

	1	2	3	4	5	6	7	8	9	10
A	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
B	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
C	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
D	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
E	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
F	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
G	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
H	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
I	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
J	Cer	Cer	Cer	Cer	Cer	Cer					_ma

	1	2	3	4	5	6	7	8	9	10
A	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
B	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
C	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
D	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
E	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
F	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
G	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
H	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
I	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
J	Cer	Cer	Cer	Cer	Cer	Cer					_ma

	1	2	3	4	5	6	7	8	9	10
A	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
B	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
C	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
D	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
E	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
F	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
G	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
H	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
I	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer	Cer
J	Cer	Cer	Cer	Cer	Cer	Cer					_ma